SEC Filings for Compugen Ltd. (CGEN)

$ 14.97   -0.89 (-5.61%) Volume: 1.75m 4:00 PM EDT 13-Jul-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934209/06/2017
CT ORDERConfidential treatment order108/14/2017
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934508/02/2017
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934207/26/2017
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934107/14/2017
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934107/13/2017
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934205/31/2017
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934205/30/2017
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934205/25/2017
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934205/09/2017
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934203/28/2017
20-FRegistration statement / Annual report / Transition report602/16/2017
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934202/15/2017
SC 13GStatement of acquisition of beneficial ownership by individuals202/14/2017
SC 13GStatement of acquisition of beneficial ownership by individuals102/01/2017
123456789101112131415